-
Functional Areas
- Audit and Investigations
-
Capacity development and transition, strengthening systems for health
- A Strategic Approach to Capacity Development
- Capacity Development and Transition - Lessons Learned
- Capacity development and Transition Planning Process
- Capacity Development and Transition
- Capacity Development Objectives and Transition Milestones
- Capacity Development Results - Evidence From Country Experiences
- Functional Capacities
- Interim Principal Recipient of Global Fund Grants
- Legal and Policy Enabling Environment
- Overview
- Resilience and Sustainability
- Transition
-
Financial Management
- CCM Funding
- Grant Closure
- Grant Implementation
- Grant-Making and Signing
- Grant Reporting
- Import duties and VAT / sales tax
- Overview
- Sub-recipient Management
-
Grant closure
- Overview
-
Steps of Grant Closure Process
- 1. Global Fund Notification Letter 'Guidance on Grant Closure'
- 2. Preparation and Submission of Grant Close-Out Plan and Budget
- 3. Global Fund Approval of Grant Close-Out Plan
- 4. Implementation of Close-Out Plan and Completion of Final Global Fund Requirements (Grant Closure Period)
- 5. Operational Closure of Project
- 6. Financial Closure of Project
- 7. Documentation of Grant Closure with Global Fund Grant Closure Letter
- Terminology and Scenarios for Grant Closure Process
- Human resources
- Human rights, key populations and gender
-
Legal Framework
- Agreements with Sub-recipients
- Agreements with Sub-sub-recipients
- Amending Legal Agreements
- Implementation Letters and Performance Letters
- Language of the Grant Agreement and other Legal Instruments
- Legal Framework for Other UNDP Support Roles
- Other Legal and Implementation Considerations
- Overview
- Project Document
- Signing Legal Agreements and Requests for Disbursement
-
The Grant Agreement
- Grant Confirmation: Conditions Precedent (CP)
- Grant Confirmation: Conditions
- Grant Confirmation: Face Sheet
- Grant Confirmation: Schedule 1, Integrated Grant Description
- Grant Confirmation: Schedule 1, Performance Framework
- Grant Confirmation: Schedule 1, Summary Budget
- Grant Confirmation: Special Conditions (SCs)
- Grant Confirmation
- UNDP-Global Fund Grant Regulations
-
Monitoring and Evaluation
- Differentiation Approach
- Monitoring and Evaluation Components of Funding Request
- M&E Components of Grant Implementation
- Monitoring and Evaluation Components of Grant Making
- Overview
- Principal Recipient Start-Up
-
Health Product Management
- Compliance with the Global Fund requirements
- Distribution
- Inspection and Receipt
- International freight, transit requirements and use of INCOTERMS
- Inventory Management
- Overview - Health Product Management
- Pharmacovigilance
- Product Selection
- Quality monitoring of health products
- Quantification and Forecasting
- Rational use
- Risk Management for PSM of health products
-
Sourcing and regulatory aspects
- Development of List of Health Products
- Development of the Health Procurement Action Plan (HPAP)
- Global Health Procurement Center (GHPC)
- Guidance on donations of health products
- Health Procurement Architecture
- Local Procurement of health products
- Other Elements of the UNDP Procurement Architecture
- Procurement of non-pharmaceutical Health Products
- Procurement of Pharmaceutical Products
- Submission of GHPC CO Procurement Request Form
- Storage
- Supply Planning of Health Products
- UNDP Health PSM Roster
- Waste management
- Grant Reporting
-
Risk Management
- Introduction to Risk Management
- Overview
- Risk management in crisis settings
-
Risk Management in the Global Fund
- Additional Safeguard Policy
- Challenging Operating Environment (COE) Policy
- Global Fund Review of Risk Management During Grant Implementation
- Global Fund Risk Management Framework
- Global Fund Risk Management Requirements During Funding Request
- Global Fund Risk Management Requirements for PRs
- Local Fund Agent
- Risk management in UNDP
- Risk Management in UNDP-managed Global Fund projects
- UNDP Risk Management Process
- Sub-Recipient Management
International freight
Five basic modes of freight transportation – sea, rail, road, air and parcel post – are used, either individually or in combination, in international transportation. In general, rail, road, and air transport costs are comparatively higher than freight by sea, thus UNDP generally recommends sea transport. However, air freight has a shorter duration than sea and land freight, and should always be selected for health products that require “cold chain” conditions (categories [2-8°C] and below 0°C categories). For health products that do not require “cold chain” conditions, any mode of transport (air, sea, land) can be used. The most economical route should be selected based on when products are needed in-country.
During the procurement process, the proper transport conditions, for the products to be shipped, must be requested from the supplier and/or freight forwarder – this can be verified in the transport documents provided by the supplier or the freight company (i.e., airwaybill/bill-of-lading).
Distributors, wholesalers and any parties involved in the supply chain should comply with WHO Good Storage and Distribution practices (GSDP) and with Module 5 of WHO’s MQAS. Shipment containers and vehicles used for transportation should be secured. Transport conditions of medicines and other health products should ensure that their quality is preserved throughout the chain, in accordance with the manufacturer’s instructions.
To support UNDP COs in monitoring the health procurement managed through the GHPC, the HPS team has developed an SOP for Shipment Tracking and Payment and will launch the Delivery Tracking Dashboard, shortly.
Use of dataloggers
Dataloggers are electronic devices that record temperature and/or humidity conditions and should be used in international shipments of health products, be it by air, sea or land. Therefore, UNDP COs should request inclusion of temperature dataloggers during the procurement process. Before placing/confirming a purchase order, UNDP CO needs to verify that dataloggers have been included in the supplier’s offer; if not, the CO should ask the supplier to include it and amend the offer, accordingly.
The UNDP HPS Team (HPS) has established multiple Long-Term Agreements (LTAs) for the supply of dataloggers to ensure adequate temperature monitoring of shipments, in-country distribution and storage. The LTAs and corresponding SOPs are available here.
Special Requirements for Narcotic and Psychotropic substances
When controlled products are requested, the recipient in the country should obtain an import authorization from the National Regulatory Authority (NRA). The import authorization should clearly indicate the name of the medicine (in INN), the concentration in active ingredients and the quantities of medicines requested.
The import authorization must be sent to the supplier (distributor or manufacturer) who will then request their local National Regulatory Authority to issue the export license (exactly the same product, concentrations and quantities).
- Controlled products containing narcotic or psychotropic substances should be transported in secured containers and in accordance with the requirements established by the NRA.
- In addition to the above, cartons must be palletized (whenever possible) and covered by a protective film.